Buettner V L, Hill K A, Nishino H, Schaid D J, Frisk C S, Sommer S S
Department of Biochemistry and Molecular Biology, Mayo Clinic/Foundation, Rochester, Minnesota 55905, USA.
Oncogene. 1996 Dec 5;13(11):2407-13.
p53 (-/-), lacI (+/-) double transgenic (p53/Big Blue3) mice provide an opportunity to examine the relationship in vivo between somatic mutation and tumorigenesis. Previously, the frequency and spectra of lacI mutations were found to be similar in normal tissues of 6 week old p53 (-/-) lacI (+/-) and p53 (+/+) lacI (+/-) mice. Herein, p53 (-/-), lacI (+/-) mice were used to examine the frequency and spectrum of spontaneous mutation in thymic lymphomas. Four mice with thymic lymphomas were sacrificed at 2.5, 3, 4 and 4.5 months of age. Normal thymus harvested from two p53 (+/+) lacI (+/-) mice and two p53 (-/-) lacI (+/-) mice served as controls. The mutation frequency in tumor 108 (6.8 x 10(-5)) was elevated 2.3-fold relative to the p53 (-/-) control (P<0.0001; chi2 test). The mutation spectra were also different (P=0.0009; Fisher exact test); in particular, A:T-->G:C transitions were prominently overrepresented in tumor 108. In addition, there were two examples of unusual deletions with inversions. In tumors 44 and 115, but not 110, there were trends toward increased mutation frequencies and altered spectra, but, within the constraints of present sample sizes, the results are not statistically significant. In conclusion, these findings suggest that altered frequencies and spectra exist in a subset of thymic lymphomas, perhaps due to somatic mutation in one or more DNA repair genes.
p53基因敲除(-/-)、乳糖抑制蛋白基因杂合(+/-)的双转基因(p53/大蓝3)小鼠为研究体细胞突变与肿瘤发生在体内的关系提供了一个机会。此前发现,6周龄的p53基因敲除(-/-)乳糖抑制蛋白基因杂合(+/-)小鼠和p53基因正常(+/+)乳糖抑制蛋白基因杂合(+/-)小鼠的正常组织中,乳糖抑制蛋白基因(lacI)突变的频率和谱相似。在此,利用p53基因敲除(-/-)、乳糖抑制蛋白基因杂合(+/-)小鼠来检测胸腺淋巴瘤中自发突变的频率和谱。4只患有胸腺淋巴瘤的小鼠分别在2.5、3、4和4.5月龄时被处死。从2只p53基因正常(+/+)乳糖抑制蛋白基因杂合(+/-)小鼠和2只p53基因敲除(-/-)乳糖抑制蛋白基因杂合(+/-)小鼠获取的正常胸腺作为对照。肿瘤108中的突变频率(6.8×10⁻⁵)相对于p53基因敲除(-/-)对照升高了2.3倍(P<0.0001;卡方检验)。突变谱也不同(P = 0.0009;Fisher精确检验);特别是,肿瘤108中A:T→G:C转换明显过多。此外,有两个不寻常的缺失伴倒位的例子。在肿瘤44和115中,但在肿瘤110中未出现,有突变频率增加和谱改变的趋势,但在当前样本量的限制下,结果无统计学意义。总之,这些发现表明,一部分胸腺淋巴瘤存在频率和谱的改变,可能是由于一个或多个DNA修复基因的体细胞突变所致。